Literature DB >> 18263963

Treatment planning using tailored and standard cylindrical light diffusers for photodynamic therapy of the prostate.

Augusto Rendon1, J Christopher Beck, Lothar Lilge.   

Abstract

Interstitial photodynamic therapy (PDT) has seen a rebirth, partially prompted by the development of photosensitizers with longer absorption wavelengths that enable the treatment of larger tissue volumes. Here, we study whether using diffusers with customizable longitudinal emission profiles, rather than conventional ones with flat emission profiles, improves our ability to conform the light dose to the prostate. We present a modified Cimmino linear feasibility algorithm to solve the treatment planning problem, which improves upon previous algorithms by (1) correctly minimizing the cost function that penalizes deviations from the prescribed light dose, and (2) regularizing the inverse problem. Based on this algorithm, treatment plans were obtained under a variety of light delivery scenarios using 5-15 standard or tailored diffusers. The sensitivity of the resulting light dose distributions to uncertainties in the optical properties, and the placement of diffusers was also studied. We find that tailored diffusers only marginally outperform conventional ones in terms of prostate coverage and rectal sparing. Furthermore, it is shown that small perturbations in optical properties can lead to large changes in the light dose distribution, but that those changes can be largely corrected with a simple light dose re-normalization. Finally, we find that prostate coverage is only minimally affected by small changes in diffuser placement. Our results suggest that prostate PDT is not likely to benefit from the use of tailored diffusers. Other locations with more complex geometries might see a better improvement.

Mesh:

Year:  2008        PMID: 18263963      PMCID: PMC2649773          DOI: 10.1088/0031-9155/53/4/021

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  31 in total

1.  Design and performance of thin cylindrical diffusers created in Ge-doped multimode optical fibers.

Authors:  Leonid Vesselov; William Whittington; Lothar Lilge
Journal:  Appl Opt       Date:  2005-05-10       Impact factor: 1.980

2.  Advances in photodynamic therapy for the treatment of head and neck cancers.

Authors:  M Biel
Journal:  Lasers Surg Med       Date:  2006-06       Impact factor: 4.025

3.  Photodynamic therapy in the canine prostate using motexafin lutetium.

Authors:  R A Hsi; A Kapatkin; J Strandberg; T Zhu; T Vulcan; M Solonenko; C Rodriguez; J Chang; M Saunders; N Mason; S Hahn
Journal:  Clin Cancer Res       Date:  2001-03       Impact factor: 12.531

4.  Determination of the distribution of light, optical properties, drug concentration, and tissue oxygenation in-vivo in human prostate during motexafin lutetium-mediated photodynamic therapy.

Authors:  Timothy C Zhu; Jarod C Finlay; Stephen M Hahn
Journal:  J Photochem Photobiol B       Date:  2004-12-02       Impact factor: 6.252

5.  Studies of tin ethyl etiopurpurin photodynamic therapy of the canine prostate.

Authors:  S H Selman; D Albrecht; R W Keck; P Brennan; S Kondo
Journal:  J Urol       Date:  2001-05       Impact factor: 7.450

6.  In vivo light transmission spectra in EMT6/Ed murine tumors and Dunning R3327 rat prostate tumors during photodynamic therapy.

Authors:  A M Ballangrud; O Barajas; A Georgousis; G G Miller; R B Moore; M S McPhee; J Tulip
Journal:  Lasers Surg Med       Date:  1997       Impact factor: 4.025

7.  Optical characteristics of the canine prostate at 665 nm sensitized with tin etiopurpurin dichloride: need for real-time monitoring of photodynamic therapy.

Authors:  Jerzy Jankun; Lothar Lilge; Alexander Douplik; Rick W Keck; Maciej Pestka; Maria Szkudlarek; Phillip J Stevens; Robert J Lee; Steven H Selman
Journal:  J Urol       Date:  2004-08       Impact factor: 7.450

8.  In vivo optical properties of normal canine prostate at 732 nm using motexafin lutetium-mediated photodynamic therapy.

Authors:  Timothy C Zhu; Stephen M Hahn; Amy S Kapatkin; Andreea Dimofte; Carmen E Rodriguez; Teodor G Vulcan; Eli Glatstein; R Alex Hsi
Journal:  Photochem Photobiol       Date:  2003-01       Impact factor: 3.421

9.  In vivo optical characterization of human prostate tissue using near-infrared time-resolved spectroscopy.

Authors:  Tomas Svensson; Stefan Andersson-Engels; Margrét Einarsdóttír; Katarina Svanberg
Journal:  J Biomed Opt       Date:  2007 Jan-Feb       Impact factor: 3.170

Review 10.  Photodynamic therapy: a new approach to prostate cancer.

Authors:  Rolf Muschter
Journal:  Curr Urol Rep       Date:  2003-06       Impact factor: 2.862

View more
  4 in total

Review 1.  Vascular targeted photochemotherapy using padoporfin and padeliporfin as a method of the focal treatment of localised prostate cancer - clinician's insight.

Authors:  Andrzej M Bugaj
Journal:  World J Methodol       Date:  2016-03-26

2.  Interstitial PDT using diffuser fiber-investigation in phantom and in vivo models.

Authors:  Mirian D Stringasci; Thereza C Fortunato; Lilian T Moriyama; José Dirceu Vollet Filho; Vanderlei S Bagnato; Cristina Kurachi
Journal:  Lasers Med Sci       Date:  2017-05-05       Impact factor: 3.161

Review 3.  Photodynamic nanomedicine in the treatment of solid tumors: perspectives and challenges.

Authors:  Alyssa Master; Megan Livingston; Anirban Sen Gupta
Journal:  J Control Release       Date:  2013-03-06       Impact factor: 9.776

Review 4.  Photodynamic therapy for treatment of solid tumors--potential and technical challenges.

Authors:  Zheng Huang; Heping Xu; Arlen D Meyers; Ali I Musani; Luowei Wang; Randall Tagg; Al B Barqawi; Yang K Chen
Journal:  Technol Cancer Res Treat       Date:  2008-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.